Seelos Therapeutics, Inc. (SEELQ)
0.0001
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Seelos Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.361 |
| March 31, 2024 | -0.3968 |
| December 31, 2023 | -0.4246 |
| September 30, 2023 | -0.5559 |
| June 30, 2023 | -0.3252 |
| March 31, 2023 | -0.8122 |
| December 31, 2022 | -1.896 |
| September 30, 2022 | 2.716 |
| June 30, 2022 | 0.7349 |
| March 31, 2022 | 0.4205 |
| December 31, 2021 | 0.3307 |
| September 30, 2021 | 0.0007 |
| June 30, 2021 | 0.0009 |
| March 31, 2021 | 0.2269 |
| December 31, 2020 | 3.781 |
| September 30, 2020 | 0.022 |
| June 30, 2020 | 0.0397 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.5189 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | -0.8848 |
| September 30, 2016 | -0.9781 |
| June 30, 2016 | -0.8548 |
| March 31, 2016 | -1.278 |
| December 31, 2015 | -0.9454 |
| September 30, 2015 | -1.248 |
| June 30, 2015 | -1.50 |
| March 31, 2015 | 2.891 |
| December 31, 2014 | 2.493 |
| September 30, 2014 | 0.1003 |
| June 30, 2014 | 0.0997 |
| March 31, 2014 | 0.2991 |
| December 31, 2013 | 0.237 |
| September 30, 2013 | 0.2129 |
| June 30, 2013 | 0.1857 |
| March 31, 2013 | -5.573 |
| September 30, 2012 | 0.1699 |
| June 30, 2012 | 0.2388 |
| March 31, 2012 | 0.1994 |
| December 31, 2011 | 0.8353 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.2335 |